Breakthroughs in Metastatic Breast Cancer From ESMO 2021 Breakthroughs in Metastatic Breast Cancer From ESMO 2021

Dr Javier Cortes presents practice-changing data on metastatic breast cancer from ESMO 2021, including trastuzumab deruxtecan in HER2+ disease, pembrolizumab in TNBC, and ribociclib in HR+/HER2- disease.Medscape

Source: Medscape Today Headlines - October 8, 2021 Category: Consumer Health News Tags: None ReCAP Source Type: news